BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24481676)

  • 1. OCT3 and SOX2 promote the transformation of Barrett's esophagus to adenocarcinoma by regulating the formation of tumor stem cells.
    Wang X; Yang S; Zhao X; Guo H; Ling X; Wang L; Fan C; Yu J; Zhou S
    Oncol Rep; 2014 Apr; 31(4):1745-53. PubMed ID: 24481676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
    Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
    Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus.
    van Olphen S; Biermann K; Spaander MC; Kastelein F; Steyerberg EW; Stoop HA; Bruno MJ; Looijenga LH
    Am J Gastroenterol; 2015 Oct; 110(10):1420-8. PubMed ID: 26323187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.
    Peng DF; Hu TL; Soutto M; Belkhiri A; El-Rifai W
    Carcinogenesis; 2014 Jul; 35(7):1620-8. PubMed ID: 24692067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.
    Grotenhuis BA; Dinjens WN; Wijnhoven BP; Sonneveld P; Sacchetti A; Franken PF; van Dekken H; Tilanus HW; van Lanschot JJ; Fodde R
    J Pathol; 2010 Aug; 221(4):379-89. PubMed ID: 20549647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Oct3/4-positive cells from a human bronchial epithelial cell line.
    Li X; Jia L; Jia X; Shi M; Li X; Ye X; Wang R; Xiong Y; Wang E; Li F
    APMIS; 2013 Jul; 121(7):612-25. PubMed ID: 23216104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa.
    von Rahden BH; Kircher S; Kafka M; Stuermer L; Reiber C; Gattenlöhner S; Germer CT; Grimm M
    Cancer Biomark; 2010; 7(6):285-94. PubMed ID: 21694467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.
    Mendelson J; Song S; Li Y; Maru DM; Mishra B; Davila M; Hofstetter WL; Mishra L
    Cancer; 2011 Aug; 117(16):3691-702. PubMed ID: 21305538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.
    Taylor C; Loomans HA; Le Bras GF; Koumangoye RB; Romero-Morales AI; Quast LL; Zaika AI; El-Rifai W; Andl T; Andl CD
    Oncotarget; 2015 Oct; 6(33):34228-44. PubMed ID: 26447543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; van Zoest KP; Moons LM; Hansen B; Pot RG; Siersema PD; Kusters JG; Kuipers EJ
    Scand J Gastroenterol; 2012 Apr; 47(4):378-86. PubMed ID: 22243485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
    Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia.
    Anders M; Rösch T; Küster K; Becker I; Höfler H; Stein HJ; Meining A; Wiedenmann B; Sarbia M
    Cancer Gene Ther; 2009 Jun; 16(6):508-15. PubMed ID: 19132065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.